The present study demonstrates that murine dermal fibroblasts produce nitrite (N02 -) and nitrate (N03 -) upon treatment with interferon y (IFN-y) . This formation is dependent on L-arginine and can be inhibited by the L-arginine analogue NG-monomethyl-L-arginine. The effect ofIFN-y is drastically increased by cotreatment with tumor necrosis factor a (TNF-a), interleukin 1 (IIr1), or lipopolysaccharide (LPS) . The tested cytokines also induce formation of tetrahydrobiopterin in murine fibroblasts. Inhibition of guanosine triphosphate-cyclohydrolase I, the key enzyme of tetrahydrobiopterin de novo synthesis with 2,4-diamino-6-hydroxy-pyrimidine, leads to decreased formation of N02 -and N03 -. This effect can be reversed by addition of sepiapterin, which provides tetrahydrobiopterin via a salvage pathway. Methotrexate, which inhibits the salvage pathway, blocks the restoration of N02 -and N03 -production by sepiapterin . The cytotoxic effect of combinations ofIFN-a with TNF-y, IW, or LPS is attenuated by inhibition of tetrahydrobiopterin synthesis . These results show that intracellular concentrations of tetrahydrobiopterin control the amount of N02 -and N03 -produced in situ and suggest that the role of cytokine-induced tetrahydrobiopterin synthesis is to provide cells with the active cofactor for production of nitrogen oxides.
rine macrophages (8, 9) . Further, we found recently in mouse dermal fibroblasts that tetrahydrobiopterin synthesis is stimulated by IFN-y and even better by TNF-a, or combination of IFN-y with TNF-a (Werner, E. R., G. Werner-Felmayer, D. Fuchs, A. Hausen, G. Reibnegger, J. J. Yim, and H. Wachter, manuscript submitted for publication) .
Although cytokine-induced pteridine synthesis thus seems to be a general phenomenon in mammalian cells, no biological function could so far be established . Tetrabydrobiopterin is an essential cofactor of phenylalanine 4-, tyrosine 3-, and tryptophan 5-monooxygenase (10) . However, we could not find that these enzyme activities were induced in IFN-y-treated cells (unpublished data). Moreover, there is no evidence that oxidation of etherlipids, the fourth established tetrahydrobiopterin-dependent reaction (11) , is influenced by IFN-y.
Recently, a new tetrahydrobiopterin-requiring reaction, the formation of nitrogen oxides from L-arginine, was described for cell homogenates of mouse macrophages (8, 9) . This oxidation of L-arginine is induced in murine macrophages by treatment with LPS (12) or lymphokines, such as IFN-y (13) . The effect of IFN-y can be further enhanced by cotreatment with TNF-a, TNF-a, or LPS (14, 15) . Since pteridine synthesis is modulated by the same factors, it appeared attractive to hypothesize that cytokines induce formation oftetrahydrobiopterin in order to provide a cofactor for the generation of nitrogen oxides . If this was true, pteridine-dependent formation of nitrogen oxides should not only occur in macrophages but also in other cells with inducible pteridine synthesis, e.g., in fibroblasts .
In this report, we show that murine fibroblasts can be stimulated by IFN-y to release nitrite (N02 -) and nitrate (N03 -). The effect of IFN-y is enhanced by TNF-ac, IL1, or LPS. Data obtained by inhibition and restoration of pteridine synthesis indicate that tetrahydrobiopterin is essential for the formation of N02-and N03 -, and that generation of nitrogen oxides is related to cytokine-mediated cytotoxicity.
Materials and Methods
Materials. Mouse rIFN-y (produced in Chinese hamster ovary cells) was obtained from Holland Biotechnology (Leiden, The Netherlands) and had a specific activity of 10' U/mg of protein.
Mouse ffNF-a (4 x 10' U/mg protein; produced in Escherichia coli was a kind gift of Dr. G.R. Adolph (Bender Co., Vienna, Austria). Human rIIrl-a (10' U/mg protein; expressed in E. colt) was from Genzyme (Boston, MA). LPS from E. coli 055:B5 (phenolic extract), 2,4-diamino-6-hydroxy-pyrimidine (DAHP), and methotrexate were from Sigma Chemical Co. (Munich, FRG) . N'G-monomethyl-L-arginine (NMA) was from Calbiochem-Behring Corp. (La Jolla, CA). Pteridines were from Dr. B. Schircks aona, Switzerland).
Cell Culture. Murine fibroblasts were kindly provided by Dr. C. Heufler (Department of Dermatology, University of Innsbruck) . Cells were established from ear dermis explants of 8-10-wk-old BALB/c mice, which were cultured in RPMI 1640 (Biochrome, Berlin, FRG) containing 10% heat-inactivated FCS (Biochrome), 2 mM L-glutamine,100 U/ml of penicillin, and 0.1 ng/ml of streptomycin (Sigma Chemical Co.) . All cultures were maintained in humidified air containing 5% C02 at 37°C with a medium change every week . Nonadherent cells were removed by washing. After 4 wk, cells grown out from the explants were passaged by trypsinization and further propagated by a weekly transfer of 1:3 . Cells were determined to be fibroblasts due to morphological features, growth characteristics, and MHC antigen expression. The resulting cell population, forming a monolayer, consisted of multipolar cells, assuming a pavement-like and partly spindle-shaped appearance when confluent, as is characteristic for mouse fibroblasts . Cells ceased to grow when confluent, and no formation of foci was observed. For isolation and culture of cells, no pretreatment of surfaces or supply with growth factors except FCS was provided . Under these standard conditions, only fibroblasts survive in the culture. MHC class I antigen expression of these cells was enhanced two-to threefold by IFN-y (5-500 U/ml) as compared with untreated controls and untreated control cells, and IFN-y-stimulated cells were negative for MHC class II antigen. This was reported previously for 3T3 mouse fibroblasts (16) . MHC antigen expression was detected by ELISA as performed previously (17) . Cells grown in 96-well plates were stained with either undiluted supernatant from 34-1-2S hybridoma (Kd, Dd ; American Type Culture Collection, Rockville, MD) or with 20 ng/well of purified antibody reacting with I-Ad (Becton Dickinson & Co., Mountain View, CA) andwith a horseradish peroxidase-conjugated second antibody to mouse IgG whole molecule (Sigma Chemical Co.). Cells of passages 10-25 were used for experiments .
Formation of NOz-and NOZ-+ N0,, -. Fibroblasts were seeded at a density of 1( 5/ml in 24-well culture plates (Falcon Lab-
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Biopterin-dependent Formation of Nitrogen Oxides in Fibroblasts ware, Oxnard, CA) and grown to confluency with one change of medium on day 4 of culture, using RPMI 1640 (supplemented as described above). On day 8, cells were treatedwith cytokines and/or other additives. Due to its low content of nitrate, all incubations were carried outin DMEM (Serva, Heidelberg, FRG), supplemented as described above. We tested different doses of DAHP (1-10 mM), sepiapterin (50-400 ,AM), and methotrexate (10-100 uM). Optimal doses were 5 mM for DAHP, 100 AM for sepiapterin, and 10 AM for methotrexate, and were used throughout all further experiments. Accordingly, other pteridines were used at a concentration of 100 AM . In the case of methotrexate treatment, the medium was supplemented with 40 AM thymine and 100 AM inosine (Fluka, Buchs, Switzerland). All additiveswere dissolvedin complete DMEM, and, where necessary, the pH was adjusted to 7.4 . The additives were applied to cellsjust before cytokines. In the case of cytokine combinations, TNF-a, IIA, or LPS were added immediately after IFN-y (i .e., within 1 min), which was essential for optimal stimulation. The final volume per well was 1 ml . NMA was applied to cells 24 h before stimulation with cytokines.
For some experiments, confluent monolayers were treated for 7 h with cultured medium with or without L-arginine (MEM/Earle, Select Amine Kit; Gibco Laboratories, Grand Island, NY), containing serum, glutamine, and antibiotics (see above) . After changing the respective medium once again, cells were stimulated with cytokines.
After incubation for 72 h, supernatants were harvested. Monolayers were washed once with warm PBS and were lysed with 0.05 M H3P04 for protein determination . N0 2-was measured in supernatants as described (18) , using the stable Griess-Ilosvay's nitrite reagent obtained from Merck (Darmstadt, FRG) . N03 was reducedenzymatically by 0.125 Wmol/min of nitrate reductase (EC 1.6 .6 .2) from Aspergillus sp. (Serva), and2.5 mM nicotinamide adenine dinucleotide phosphate, reduced form, and was then measured as N02-(designated NOz-+ N03-). Background levels were determined in cell-free controls of culture medium with or without additives and were subtracted for calculation of the total amount of nitrogen oxides formed . Data are presented as micromoles per liter. The detection limit of N02-was 1 Amol/liter. Approximate values in nanomoles per milligram of total cell protein or nanomoles per 105 cells can be calculated from the protein values given below.
Determination of Intracellular Biopterin. Fibroblasts were seeded in 25-CM2 culture flasks (Falcon Labware) at a density of 105/ml in 5 ml of complete RPMI 1640 and grown to confluency with one medium change . On day 8, cells were treated with cytokines, DAHP, methotrexate, and sepiapterin in a final volume of 5 ml of complete DMEM (for details, see above). After 72 h, supernatants were collected for detection of N02-and N0 2-+ N03-(see above) . Absolute values of nitrogen oxides presented in Table  2 (see Results) are higher than in the other experiments shown. This was due to the use of culture flasks (25 cmz/5 ml) instead of 24-well plates (2 cmz/ml), resulting in a different cell to supernatant ratio.
Cells were harvested by trypsinization and washed with PBS. Pellets were resuspended in 250 Al of distilled water, rapidly frozen in liquid nitrogen, and kept at -20°C until oxidation, which was started within 1 h after freezing. Samples were thawed one by one, centrifuged for 2 min at 10,000,g, and subjected to oxidation with iodine at acidic or alkaline pH (19) . Briefly, 100 Al of cell extracts were mixed with 5 A1 of 1 M HCl and 5 Al of 0.1 M K1/12 in order to determine the totalamount of biopterin, including 5,6,7,8-tetrahydro and 7,8-dihydro derivatives. Another 100 Al of cell extract was mixed with 5 AI of 1 M NaOH and 5 141 of 0.1 M KI/Iz for destroying the tetrahydro derivative, thus detecting the sum of 7,8-dihydrobiopterin and biopterin . After incubation for 1 h in the dark at room temperature, samples were centrifuged for 2 min at 10,000 g, and the supernatant was mixed with 10 Al of 0.1 M ascorbic acid. Samples were stored at -20°C until HPLC analyses (LC 5500; Varian Associates, Inc ., No Alto, CA). Samples were then extracted with AASPSCX cartridges (Analytichem International, Inc ., Harbor City, CA), and pteridines were directly eluted onto a reversed-phase HPLC column (Lichrosorb, RP-18, 7-,urn particle size, Merck) and quantified by fluorescence detection (LS 4, Perkin-Elmer Corp., Beaconsfield, UK), as previously described (20) . Values are presented as picomoles per milligram of total cell protein .
Cell Viability Assay. Fibroblasts (105/ml) were seeded in 100 Al/well in 96-well plates (Falcon Labware) and grown to confluency, using RPMI 1640 with supplements. We used confluent monolayers in order to limit possible effects of additives on cell growth. On day 8 ofculture, monolayers were treated with cytokines, DAHP, and pteridines in DMEM (see above) in a final volumeof 100 Al/well for 48-96 h. In some experiments, the influence of L-argininedeficient medium, of 250 Am NMA, of 10 MM L-or D-arginine, and of NMA plus 10 MM. L-or D-arginine was tested . For this purpose, confluent monolayers were pretreated with the mentioned additives 48 h before addition ofcytokines in the respective culture medium. After 48-96 h, medium was removed, and cells were washed once with 100 pl/well of warm PBS and fixed then with 5% glutaraldehyde in PBS (100 A1/well) for 10 min . Plates were washed three times with PBS. Fixed cells were stained with 0.05% methylene blue (Merck) for 5 min and washedfive times with PBS . Methylene blue, trapped in fixed cells, was solubilized with 100 Al/well of 0.33 M HCI, and OD at 620 nm was measured using a 96-well plate reader (Anthos; Labtec, Salzburg, Austria) . Relative cell viability is expressed as percent ofuntreated control cells. For each tested combination of factors, eight wells per plate were treated in parallel. In comparison with 24-well plates (2 cmz/ml) used in the other experiments, cytotoxic effects could be observed earlier (i.e., after 72-% h) in %-well plates (0.32 cmz/100 Al) due to a different cell to supernatant ratio . N02 -was determined in supernatants of individual wells as described above.
Protein Determination. Protein content of cell extracts was determined according to Bradford (21) , modified for 96-well plates, using the protein dye reagent from Bio-Rad Laboratories (Richmond, CA) and BSA (Serva) as protein standard. Individual wells 1601
Wemer-Felmayer et al.
ofcontrol cells contained 76.6 t 7.7 pg (mean of 12 cultures ± SD) ofprotein, which was not reduced >10% by cytokine treatment for 72 h using 24-well plates and 1 ml ofculture medium. Protein content of 105 cells was 25.4 ± 2.5 Wg (mean of 10 cultures ± SD), so that the final cell number per well was N3 x 105.
Results
Induction of N02 -and NO., -Formation in Murine Fibroblasts by Cytokines. Murine fibroblasts produced N02 -and N03 -upon treatment with IFN--y in a dose-dependent manner (Fig. 1) . The effect ofIFN-y was about two-to threefold enhanced by cotreatment with TNF-a, ILl, or LPS. N02 -represented 58.2 ± 6.3% (mean of 36 cultures ± SD) of the total amount of N02 -+ N03 -, as calculated from the values given in Fig . 1. TNF-a, IL1 , or LPS were nearly ineffective as single stimuli. However, in the case of ILl, 10 U/ml was sufficient to enhance the IFN -'y effect, and 100 U/ml had only a slightly better costimulatory effect (Fig. 1 ). For LPS, optimal costimulation of 50 U/ml ofIFN-y was achieved at 100 ng/ml. LPS doses higher than 100 ng/ml did not further enhance the effect of IFN-y. Maximal production of N02 -was observed upon treatment of cells with 50 U/ml IFN--y in combination with 500 U/ml of TNF-a (Fig. 1 ). This cytokine combination was therefore used in further experiments. Fig . 2 shows the time course of N02 -and N02 -+ N03 -formation upon stimulation with 50 U/ml of IFN-y in combination with either 500 U/ml TNF-a, 100 U/ml ILl, or 10 Ag/ml LPS. Despite the cytotoxic effects of these cytokines (see below), which can be observed after >72 h, there is a steady increase of N02 -and N02 -+ N03 -in the supernatants over 144 h. Protein content of control cells was 82.0 t 4.0 Ag (mean of three cultures ± SD) at the beginning of the experiment, and 80. The L-arginine analogue NMA inhibited cytokine-induced formation of N02 -and N02 -+ N03 -in a dosedependent way (Fig. 3) . Already, 25 14M of NMA was sufficient to decrease the amount of N02 -significantly from 38.4 ± 1.1 Amol/liter to 28.2 ± 0.7 p,mol/liter (mean of three cultures ± SD, p < 0.001) . Production of N02 -+ N03 -was impaired in parallel. About 60 AM NMA was necessary for a 50% inhibition of nitrogen oxide formation (Fig. 3) .
Effect of Modulation of Pteridine Synthesis on Formation of
N02 -and N02-+ N03 -. Data given in Table 1 demonstrate that formation of N02 -upon treatment with IFN-y alone or in combination with TNF-ci, IIJl, or LPS was significantly decreased by treatment of cells with DAHP This compound inhibits GTP-cyclohydrolase I, the key enzyme of tetrahydrobiopterin synthesis (22) . The effect of IFN-y on N02 -formation was thereby decreased to 22% (p < 0.0001), the effect of combined stimuli was reduced to 130-50% (p < 0.001 for IFN-y/IIr1 and IFN-y/LPS ; p < 0.0001 for IFN-y/TNF-a). Addition of 100 AM sepiapterin, which provides tetrahydrobiopterin via a salvage pathway (2), reversed the effect of DAHP. Further, when given without DAHP, sepiapterin enhanced the effect of cytokine combinations on N02 -formation by 20-40%. In the case of IFN-y alone, no such stimulation was observed (Table 1) . Unconjugated pteridines not yielding tetrahydrobiopterin (2), such as pterin 6-carboxylic acid and isoxanthopterin, did not influence cytokine-induced N02-formation or the effects of DAHP (Table 1) . Table 2 relates these findings to intracellular biopterin concentrations . Treatment of fibroblasts with IFN-y/TNF-a resulted in an about threefold increase of intracellular tetrahydrobiopterin levels. Sepiapterin was converted into tetrahydrobiopterin in untreated control cells as well as in cells treated with IFN-y/TNF-a . This conversion occurs due to sepiapterin reductase and further reduction of 7,8-dihydro- biopterin into tetrahydrobiopterin by dihydrofolate reductase (EC 1.5.1.3) (2) . DAHP reduced intracellular tetrahydrobiopterin levels by -50%. Concurrent addition of DAHP and sepiapterin resulted in high intracellular tetrahydrobiopterin levels, restoring the inhibition of nitrogen oxide formation by DAHP. This reversal was inhibited by methotrexate, which interferes with formation of tetrahydrobiopterin from sepiapterin by inhibition of dihydrofolate reductase (2), thus leading to the accumulation of dihydrobiopterin. Intracellular accumulation of dihydrobiopterin even had an inhibitory effect on synthesis of N02 -and N02 -+ N03 -, as can be seen from comparison of the effects of methotrexate alone or together with sepiapterin in IFN-y/TNF-tx-stimulated cells (p < 0.01) ( Table 2 ). This may occur due to inhibition of GTP-cyclohydrolase I by dihydrobiopterin (23) . As a consequence, the combination of DAHP, methotrexate, and sepiapterin had the highest inhibiting potency. Cell Viability. Cytokine-induced formation of nitrogen oxides leads to inhibition of aconitase (EC 4.2.1.3) in tumor Confluent monolayers of murine fibroblasts were grown in 96-well plates and treated with IFN-y/TNF-a in absence or presence of DAHP, sepiapterin (SP), high doses of L-or D-arginine with or without NMA, and in L-arginine-deficient medium. At the indicated time points, cells were stained with methylene blue, and OD at 620 nm was determined after solubilizing the dye with 0.33 M HCl (see Materials and Methods) . Values are expressed as percent of viable cells relative to untreated controls ( =100%a) and give the mean of eight wells ± SD determined in one of three similar experiments . Controls after 96 h were 112 t 7 for sepiapterin, 108 ± 7 for DAHP, 96 ± 7 for NMA, 94 t 4 for NMA plus 10 MM L-arginine, 98 ± 7 for NMA plus 10 MM D-arginine, 102 ± 6 for 10 MM L-arginine, 96 ± 5 for 10 MM D-arginine, and 95 t 7 for L-arginine-deficient medium. N02 -in the respective wells was determined using the Griess reaction. " 50 U/ml IFN-y + 500 U/ml TNF-a. # + 100 AM sepiapterin . (24) as well as in activated macrophages (15, 25) . Further, it was reported previously, that IFN-y alone or in combination with IIrl, TNF-ci, or LPS is cytotoxic for murine fibroblasts (26, 27) . We therefore studied the effect of IFNy/TNF-a on cell viability in the absence or presence of DAHP or sepiapterin (Table 3) . After incubation for 96 h with IFNy/TNF-a, a decrease of cell viability to -50% became apparent . The same was observed with IFN-y in combination with IL.1 or LPS, and was less pronounced with IFN-y alone (not shown) . Table 3 shows that the cytotoxic effect of IFN-y/TNF-oc could be partially reversed by simultaneous treatment with DAHP (p < 0.01). Concurrent treatment with sepiapterin restored the cytotoxic effect of IFN-y/TNF-a, thus paralleling the effects on N02 -formation . On control cells, neither DAHP nor sepiapterin could influence cell viability (Table 3 ). The cytotoxic effect of IFN-y/TNF-ac was also reduced by treatment with NMA or by withdrawal of L-arginine . This effect of NMA was reversed by addition of L-argininebut not by D-arginine (Table 3) . Further, addition of10 mM L-arginine but not ofD-arginine to cytokine-treated cells in absence of NMA resulted in the highest cytotoxic effect (Table 3 ) (p < 0.0001 as compared with NMA plus 10 MM L-arginine) . Cell viability was significantly correlated to N02 -levels in supernatants of the respective wells (Table  3) , as determined by linear regression analysis (R = -0.78, p < 0.000001 ; 144 samples) and Spearman Rank correlation (R = -0.84, p < 0.000001 ; 144 samples) .
Discussion
In this report, we demonstrate that murine fibroblasts are capable to produce N02 -and N03 -from L-arginine upon stimulation with IFN-y . This effect of IFN-y is enhanced up to threefold by costimulation with TNF-cr, ILI, or LPS. So far, cytokine-induced formation of nitrogen oxides has been observed in murine macrophages, murine macrophage cell lines (12) (13) (14) (15) 28) , rat Kupffer cells, rat hepatocytes (29, 30) , and murine endothelial cells (31) . As in murine macrophages, N02 -is formed in fibroblasts to -50% of the totally detectable N02 -+ N03 - (13) . Further, fibroblasts produce N02 -and N03 -to an extent comparable with that found for macrophages (13) , macrophage cell lines (28) , and endothelial cells (31) . In murine macrophages, the effect ofIFN-y on formation of nitrogen oxides was enhanced by TNF-a, TNF-fl, or LPS but, in contrast to our results with fibroblasts, not by IM (14, 15) . The significance of this difference is unclear.
N02 -and N03 -originate from the oxidation of L-arginine to citrulline. This reaction can be inhibited by the L-arginine analogue NMA (32, 33) . The unstable intermediate formed initially is nitric oxide, which is converted to N02 -and N03-in the presence of oxygen (34) . Nitric oxide has been identified as a cytotoxic effector molecule of activated murine macrophages (35, 36) .
Recently, it was shown in preparations from cytosol of activated macrophages that oxidation of L-arginine requires tetrahydrobiopterin (8, 9) . Tetrahydrobiopterin was suggested to take part in the initial step of the reaction, resulting in N-hydroxylation of L-arginine (8, 9) . It was further shown that murine macrophages contain tetrahydrobiopterin (8, 9) . We show here for murine fibroblasts that cytokine-induced formation of N02 -and N03 -is paralleled by increased intracellular levels of tetrahydrobiopterin . By inhibiting tetrahydrobiopterin de novo synthesis, using the GTP-cyclohydrolase I inhibitor DAHP (22), we could demonstrate that the amount of intracellular tetrahydrobiopterin is limiting the formation of N02 -and N03 -. Resupplementing the cofactor by addition ofsepiapterin, which is converted into tetrahydrobiopterin in the cells via a salvage pathway (2), fully restores the formation of N02 -and N03 -. Methotrexate blocks this restoring effect of sepiapterin by inhibiting dihydrofolate reductase, which converts dihydrobiopterm formed from sepiapterin to the tetrahydro-derivative (2), thus underlining that only the tetrahydroderivative can serve as an active cofactor. While inhibition of tetrahydrobiopterin concentrations by DAHP significantly suppresses nitrogen oxide formation, a comparatively high amount of sepiapterin, and thus a high concentration of tetrahydrobiopterin, is necessary for restoration of nitrogen oxide formation . A possible explanation for this phenomenon could be that tetrahydrobiopterin generation from exogenously supplied sepiapterin may take place in a compartment different from the site of arginine hydroxylation, whereas endogenous tetrahydrobiopterin synthesis may supply tetrahydrobiopterin directly to the hydroxylation site.
Other unconjugated pteridines that cannot be converted to tetrahydrobiopterin due to the lack of the 1,2'-dihydroxypropyl side chain at position 6 of the pterin ring (2) could not influence formation of nitrogen oxides and the effect of DAHP Sepiapterin also enhanced the effect ofIFN-y in combination with TNF-a, IM, or LPS, but not with IFN-y alone. Thus, it seems that in presence of dual activation stimuli, the reaction forming N02 -is not saturated with tetrahydrobiopterin, although its synthesis is enhanced in parallel.
Taken together, the results obtained with DAHP, sepiapterin, and methotrexate give evidence that not only in cytosol preparations (8, 9) , but also in intact cells, tetrahydrobiopterin is essential for the production of nitrogen oxides.
The cytotoxic effect of IFN-y in combination with TNFLoi, ILl, or LPS on murine fibroblasts can be attenuated by reducing formation of nitrogen oxides via inhibition of L-arginine hydroxylation with NMA, via withdrawal OfL-arginine, or via inhibition of tetrahydrobiopterin synthesis with DAHP Addition of L-arginine and sepiapterin, respectively, restores the cytotoxic potential ofcytokine treatment . These data indicate that formation of nitrogen oxides takes part in the previously reported cytotoxic action ofIFNJy with TNF-oc, IL1, or LPS (26, 27) on murine fibroblasts. Thus, it is not only possible to influence formation of N02 -and N03 -by modulation of pteridine synthesis, but also, the biological effect of nitrogen oxides on fibroblasts.
The presented data suggest that in murine fibroblasts a major goal for cytokine-induced pteridine synthesis is to provide cells with an essential cofactor for the formation of nitrogen oxides from L-arginine. Nitric oxide, the initial product of the oxidation of L-arginine, exhibits a multitude ofbiological actions (37, 38) . It remains to be seen whether also in human cells cytokine-induced pteridine synthesis (1, (3) (4) (5) (6) (7) is related to oxidation of L-arginine and formation of nitrogen oxides.
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